1 / 48

Introduction

Introduction. What is radiation therapy (RT)?. Cancer treatment Tumor versus normal tissues External photon beam RT. Intensity-modulated RT (IMRT). Brahme et al. 1982 Fluence-modulated beams Homogeneous, concave dose distributions

luka
Download Presentation

Introduction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Introduction

  2. What is radiation therapy (RT)? • Cancer treatment • Tumor versus normal tissues • External photon beam RT

  3. Intensity-modulated RT (IMRT) • Brahme et al. 1982 • Fluence-modulated beams • Homogeneous, concave dose distributions • Better target dose conformity and/or better sparing of organs at risk (OARs)

  4. Imaging for RT

  5. Anatomical imaging • CT • MRI

  6. Biological imaging • PET • SPECT • fMRI • MRSI Brain Tumor

  7. Tumor biology characterization Apisarnthanarax and Chao 2005

  8. Biological imaging for RT • Improvement of diagnostic and staging accuracy • Guidance of target volume definition and dose prescription • Evaluation of therapeutic response

  9. Target volume definition • Gross tumor volume (GTV) • Clinical target volume (CTV) • Planning target volume (PTV)

  10. Biological target volume (BTV) Ling et al. 2000

  11. Dose painting

  12. Dose painting by contours

  13. Dose painting by numbers

  14. Dose painting by numbers Biologically Conformal Radiation Therapy

  15. Dose calculation algorithms • Speed versus accuracy: • Broad beam • Pencil beam (PB) • Convolution/superposition (CS) • Monte Carlo (MC) • Monte Carlo dose engine MCDE Reynaert et al. 2004 Accuracy ↑ Speed ↓

  16. MC dose calculation accuracy • Cross section data • Treatment beam modeling • Patient modeling • CT conversion • Electron disequilibrium • Conversion of dose to medium to dose to water • Statistical uncertainties

  17. Publications

  18. Dose Dhigh Dlow Signal intensity Ilow Ihigh Implementation of BCRT:Relationship between signal intensity and radiation dose

  19. Implementation of BCRT: Treatment planning strategy

  20. Implementation of BCRT:Biology-based segmentation tool • 2D segmentation grid in template beam’s eye view • Projection of targets (+) • Integration of signal intensities along rayline (+) • Projection of organs at risk (-) • Distance • Segment contours from iso-value lines of segmentation grid

  21. Implementation of BCRT:Objective function • Optimization of segment weights and shapes (leaf positions) • Expression of planning goals • Biological: • Tumor control probability (TCP) • Normal tissue complication probability (NTCP) • Physical: • Dose prescription

  22. Implementation of BCRT:Treatment plan evaluation QVH

  23. Implementation of BCRT:Example • [18F]FDG-PET guided BCRT for oropharyngeal cancer • PTV dose prescription:

  24. Implementation of BCRT:Example

  25. Implementation of BCRT:Example

  26. Implementation of BCRT:Conclusions • Technical solution • Biology-based segmentation tool • Objective function • Feasibility • Planning constraints OK • Best biological conformity for the lowest level of dose escalation

  27. BCRT planning study:Set-up • BCRT or dose painting-by-numbers (“voxel intensity-based IMRT”) versus dose painting (“contour-based IMRT”) • 15 head and neck cancer patients • Comparison of clinically relevant dose-volume characteristics • Between “cb250” and “vib216-250” • Between “vib216-250” and “vib216-300”

  28. BCRT planning study:Target dose prescription

  29. BCRT planning study:“cb250” (blue) versus “vib216-250” (green)

  30. BCRT planning study:“vib216-250” (green) versus “vib216-300” (orange)

  31. BCRT planning study:Example

  32. BCRT planning study:QF

  33. BCRT planning study:Conclusions • BCRT did not compromise the planning constraints for the OARs • Best biological conformity was obtained for the lowest level of dose escalation • Compared to dose painting by contours, improved target dose coverage was achieved using BCRT

  34. MC dose calculations in the clinic • Comparison of PB, CS and MCDE for lung IMRT • Comparison of 6 MV and 18 MV photons for lung IMRT • Conversion of CT numbers into tissue parameters: a multi-centre study • Evaluation of uncertainty-based stopping criteria • Feasibility of MC-based IMRT optimization

  35. CT conversion: multi-centre study • Stoichiometric calibration • Dosimetrically equivalent tissue subsets • Gammex RMI 465 tissue calibration phantom • Patient dose calculations • Conversion of dose to medium to dose to water

  36. CT conversion: example

  37. CT conversion: conclusions • Accuracy of MC patient dose calculations • Proposed CT conversion scheme: Air, lung, adipose, muscle, 10 bone bins • Validated on phantoms • Patient study: Multiple bone bins necessary if dose is converted to dose to water

  38. Conclusions

  39. Biologically conformal RT • Technical solution • Bound-constrained linear model • Treatment plan optimization • Biology-based segmentation tool • Objective function • Treatment plan evaluation • Feasibility of FDG-PET guided BCRT for head and neck cancer

  40. MC dose calculations • Individual patients may benefit from highly accurate MC dose calculations • Improvement of MCDE • CT conversion • Uncertainty-based stopping criteria • Feasibility of MC-based IMRT optimization • MCDE is unsuitable for routine clinical use, but represents an excellent benchmarking tool

  41. Outlook

  42. Adaptive RT:Inter-fraction tumor tracking • Anatomical & biological changes during RT • Re-imaging and re-planning • Ghent University Hospital: phase I trial on adaptive FDG-PET guided BCRT in head and neck cancer

  43. Summation of DVHs Dose 1 CT 2 Dose 2 CT 1 Registration Structure 1 Structure 2 Points TPoints P Doses TP Doses Total DVH Total doses

  44. Summation of QVHs PET 1 Dose 1 PET 2 CT 2 Dose 2 CT 1 Registration Registration Registration Structure 1 Structure 2 Points TPoints Disregard TPoints outside structure 2 P Q-values TP Q-values Total QVH Total Q-values

  45. Fundamental research in vitro, animal studies Radiobiology • Biological imaging • Tracers • Acquisition, reconstruction, quantification • Treatment planning and delivery • Biological optimisation • Adaptive RT Treatment outcome Nuclear medicine Radiotherapy physics Radiotherapy Clinical investigations

More Related